Hepatic Pseudoprogression after Treatment with Nectin-4-Targeted Antibody-Drug Conjugate - PubMed
4 hours ago
- #Nectin-4-Targeted Therapy
- #Antibody-Drug Conjugate
- #Hepatic Pseudoprogression
- The article discusses hepatic pseudoprogression observed in patients treated with a nectin-4-targeted antibody-drug conjugate.
- It reports on a case or series highlighting this phenomenon as a potential side effect of the therapy.
- The study is published in a medical journal with PMID: 41985141 and DOI: 10.1056/NEJMc2518316.